E
Eric J. Velazquez
Researcher at Yale University
Publications - 9
Citations - 254
Eric J. Velazquez is an academic researcher from Yale University. The author has contributed to research in topics: Retrospective cohort study & Heart failure. The author has an hindex of 6, co-authored 9 publications receiving 174 citations. Previous affiliations of Eric J. Velazquez include Duke University.
Papers
More filters
Journal ArticleDOI
The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison
Eric J. Velazquez,Zainab Samad,Hussein R. Al-Khalidi,Chithra Sangli,Paul A. Grayburn,Joseph M. Massaro,Susanna R. Stevens,Ted Feldman,Mitchell W. Krucoff +8 more
TL;DR: In this paper, the authors compared 30-day and 1-year survival among high-risk mitral regurgitation patients treated with the MitraClip (Abbott Vascular, Abbott Park, IL) with matched non-surgically treated patients from the Duke Echocardiography Laboratory Database (DELD).
Journal ArticleDOI
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
David A. Morrow,Eric J. Velazquez,Adam D. DeVore,Margaret F. Prescott,Carol I. Duffy,Yared Gurmu,Kevin McCague,Ricardo Rocha,Eugene Braunwald +8 more
TL;DR: Compared with enalapril, sacubitril/valsartan reduces myocardial injury and haemodynamic stress as reflected by biomarkers, with an onset that is apparent within 1–4 weeks.
Posted ContentDOI
Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.
Jacob McPadden,Frederick Warner,H. Patrick Young,Nathan C. Hurley,Rebecca Pulk,Avinainder Singh,Thomas J S Durant,Guannan Gong,Nihar R. Desai,Adrian D. Haimovich,Richard Andrew Taylor,Murat Gunel,Charles S. Dela Cruz,Shelli F. Farhadian,Jonathan M. Siner,Merceditas Villanueva,Keith Churchwell,Allen L. Hsiao,Charles J Torre,Eric J. Velazquez,Roy S. Herbst,Akiko Iwasaki,Akiko Iwasaki,Albert I. Ko,Bobak J. Mortazavi,Harlan M. Krumholz,Wade L. Schulz +26 more
TL;DR: Older age and male sex are identified as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection.
Journal ArticleDOI
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.
Jacob McPadden,Frederick Warner,H. Patrick Young,Nathan C. Hurley,Rebecca Pulk,Avinainder Singh,Thomas J S Durant,Guannan Gong,Nihar R. Desai,Adrian D. Haimovich,Richard Andrew Taylor,Murat Gunel,Charles S. Dela Cruz,Shelli F. Farhadian,Jonathan M. Siner,Merceditas Villanueva,Keith Churchwell,Allen L. Hsiao,Charles J Torre,Eric J. Velazquez,Roy S. Herbst,Akiko Iwasaki,Akiko Iwasaki,Albert I. Ko,Bobak J. Mortazavi,Harlan M. Krumholz,Wade L. Schulz +26 more
TL;DR: In this article, the authors identified risk factors associated with admission and disease severity in patients with severe acute respiratory syndrome virus (SARS-CoV-2) infection as determined by RT-PCR testing and assessed features associated with the need for respiratory support.
Journal ArticleDOI
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial.
David D. Berg,Marc D. Samsky,Eric J. Velazquez,Carol I. Duffy,Yared Gurmu,Eugene Braunwald,David A. Morrow,Adam D. DeVore +7 more
TL;DR: In patients stabilized during hospitalization for acute decompensated heart failure (HF), initiation of sacubitril/valsartan compared with enalapril decreased the risk of cardiovascular events.